No records
|
614 |
Rhatomy S., Setyawan R., Romulo M.A. |
57204509883;57206249736;57221505201; |
Enhancement of chondrogenesis in hypoxic precondition culture: A systematic review |
2021 |
Open Access Macedonian Journal of Medical Sciences |
9 |
|
|
492 |
504 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118498577&doi=10.3889%2foamjms.2021.5850&partnerID=40&md5=a767ee0e694f65e29d11b57b920b1f48 |
Department of Orthopaedics and Traumatology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia; Department of Orthopaedics and Traumatology, Sport and Adult Reconstructive Division, Dr. Soeradji, Tirtonegoro General Hospital, Klaten, Indonesia; Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Soeradji Tirtonegoro Sport Center and Research Unit, Dr. Soeradji Tirtonegoro General Hospital, Klaten, Indonesia |
Rhatomy, S., Department of Orthopaedics and Traumatology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia, Department of Orthopaedics and Traumatology, Sport and Adult Reconstructive Division, Dr. Soeradji, Tirtonegoro General Hospital, Klaten, Indonesia, Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Setyawan, R., Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Romulo, M.A., Soeradji Tirtonegoro Sport Center and Research Unit, Dr. Soeradji Tirtonegoro General Hospital, Klaten, Indonesia |
BACKGROUND: Cartilage tear has begun to be treated with stem cells. However, stem cell oxygen level culture has not been evaluated for the best environment to enhance chondrogenesis. AIM: The purpose of this review is to focus on the hypoxic oxygen level of stem cells culture as a treatment for cartilage tear. METHODS: A literature search was systemically conducted on PubMed (MEDLINE), OVID, EMBASE, the Cochrane Library, Scopus, Web of Science, Science Direct, Wiley Online Library, Google Scholar, and bibliography of selected articles with the terms (“culture”) AND (“stem cell” OR “mesenchymal stem cell” OR “MSC”) AND (“hypoxic” OR “hypoxia”) AND (“cartilage” OR “chondro*”) as the main keywords. A total of 438 articles were reviewed. Thirty-six articles were considered relevant for this systematic review. RESULTS: The result of this review supports stimulation effects of hypoxic oxygen level stem cell culture in chondrogenesis process. Most studies used 5% oxygen concentration for culture, both of in vivo and in vitro studies. Due to the heterogeneity nature of the included studies, meta-analysis was unable to be conducted. CONCLUSION: Hypoxia state seems to play an important role in chondrocytes proliferation, differentiation, and matrix production. © 2021 Sholahuddin Rhatomy,. |
Cartilage; Hypoxic; Oxygen level; Stem cell |
amphotericin; collagen type 1; collagen type 10; collagen type 2; elastin; glycosaminoglycan; hydroxyproline; oxygen; penicillin G; probiotic agent; streptomycin; stromal cell derived factor 1; Thy 1 membrane glycoprotein; adipose derived stem cell; biomechanics; cell culture technique; cell differentiation; cell isolation; cell proliferation; chondrogenesis; Cochrane Library; Embase; flow cytometry; gene expression; histology; human; human cell; hypoxia; hypoxic precondition culture; iliac crest; in vitro fertilization; in vitro study; in vivo study; mesenchymal stem cell; mesenchymal stem cell transplantation; natural killer cell; osteoblast; oxygen concentration; oxygen tension; phylogenetic tree; protein expression; quality control; Review; ScienceDirect; Scopus; search engine; stem ce |
Scientific Foundation SPIROSKI |
18579655 |
|
|
Review |
Q3 |
288 |
15252 |
|
|
617 |
Lestari H.M., Gustinanda J., Tejaputri N.A., Tumpu N.A., Radifan T., Louisa M. |
57223631169;57283903400;57212584722;57212585928;57283679000;41461551400; |
Stool antigen examination as a diagnostic tool for dyspeptic patient caused by helicobacter pylori infection: A case-based literature review |
2021 |
Open Access Macedonian Journal of Medical Sciences |
9 |
F |
|
305 |
309 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116395737&doi=10.3889%2foamjms.2021.5568&partnerID=40&md5=fab7a62274bf5e7787c0ca4a61924b0d |
Undergraduate Medical Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Lestari, H.M., Undergraduate Medical Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Gustinanda, J., Undergraduate Medical Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Tejaputri, N.A., Undergraduate Medical Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Tumpu, N.A., Undergraduate Medical Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Radifan, T., Undergraduate Medical Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Louisa, M., Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Today, the gold standard for diagnosing Helicobacter pylori infection is by urea breath test (UBT). However, UBT tests are not widely available in several remote areas in Indonesia. Stool antigen test (SAT) is an alternative diagnostic test for H. pylori infection. However, it is unclear whether the performance of SAT to diagnose H. pylori infection can be comparable with UBT accuracy. This report was aimed to determine the accuracy of SAT to diagnose H. pylori infection as an alternative to UBT. Our case-based literature review indicates that SAT has high sensitivity (79–96.4%); therefore, SAT can help doctors in ruling out H. pylori infection. SAT also demonstrates remarkable specificity of stool antigen examination (98.6–100%), suggesting that SAT can help doctors in ruling in H. pylori infection. © 2021 Haifa Mayang Lestari, Jatmiko Gustinanda, Nadzila Anindya Tejaputri, Nur Afiahuddin Tumpu, Taris Radifan, Melva Louisa. |
Helicobacter pylori; Stool antigen test; Urea breath test |
antigen; adult; breath analysis; case report; clinical article; decreased appetite; diagnostic accuracy; dyspepsia; enzyme immunoassay; epigastric pain; feces analysis; Helicobacter infection; human; male; meta analysis; nausea and vomiting; predictive value; prevalence; Review; systematic review; urea breath test; validity |
Scientific Foundation SPIROSKI |
18579655 |
|
|
Review |
Q3 |
288 |
15252 |
|
|
636 |
Wardhani S.O., Fajar J.K., Soegiarto G., Wulandari L., Maliga H.A., Ilmawan M., Merysa R., Simamora A.B., Aini Q., Noviantari K., Lestari A.W., Harnila M.Y., Syafi'i I., Djianzonie J.A.C., Siagian N., Nining S., Hanim R.Z., Wahyuni W., Aulia F., Juliansyah J., Mahmud R., Tamara F., Mahendra A.I., Wowor A.C., Baladraf F., Hadinata P.H., Ikkeputri A., Nadya H., Kartini D.A., Husnah M., Nainu F., Harapan H. |
57193196381;56156139600;57193717004;52464692000;57222334227;57217182580;57412905100;57413600800;57413736700;57412771300;57413600900;57413601000;57412905200;57221505199;57343359200;57413601100;57413182200;57436727400;57413458400;57412905300;57413049000;57192950403;57202301766;57413182300;57412771400;57412905400;57412771500;57413601200;57223337784;57194724156;57120069200;55844857500; |
The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: A meta-analysis. |
2021 |
F1000Research |
10 |
|
1280 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122857082&doi=10.12688%2ff1000research.74972.1&partnerID=40&md5=538e74eb0948ed728ed9150f0537f262 |
Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Division of Allergy and Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, 60286, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, 60286, Indonesia; Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Faculty of Nursing, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia; Faculty of Pharmacy, Universitas Indonesia, Jakarta, s10430, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, 60286, Indonesia; Faculty of Public Health, Universitas Indonesia, Jakarta, 10430, Indonesia; Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia; Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia; Faculty of Pharmacy, Hasanuddin University, Tamalanrea, Makassar, 90245, Indonesia; Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia; Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia |
Wardhani, S.O., Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Fajar, J.K., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Soegiarto, G., Division of Allergy and Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, 60286, Indonesia; Wulandari, L., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, 60286, Indonesia; Maliga, H.A., Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Ilmawan, M., Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Merysa, R., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Simamora, A.B., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Aini, Q., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Noviantari, K., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Lestari, A.W., Faculty of Nursing, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia; Harnila, M.Y., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Syafi'i, I., Faculty of Pharmacy, Universitas Indonesia, Jakarta, s10430, Indonesia; Djianzonie, J.A.C., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Siagian, N., Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, 60286, Indonesia; Nining, S., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Hanim, R.Z., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Wahyuni, W., Faculty of Public Health, Universitas Indonesia, Jakarta, 10430, Indonesia; Aulia, F., Faculty of Public Health, Universitas Indonesia, Jakarta, 10430, Indonesia; Juliansyah, J., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Mahmud, R., Faculty of Nursing, Universitas Indonesia, Jakarta, 10430, Indonesia; Tamara, F., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Mahendra, A.I., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Wowor, A.C., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Baladraf, F., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Hadinata, P.H., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Ikkeputri, A., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Nadya, H., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Kartini, D.A., Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia; Husnah, M., Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia; Nainu, F., Faculty of Pharmacy, Hasanuddin University, Tamalanrea, Makassar, 90245, Indonesia; Harapan, H., Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia, Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia, Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, 23111, Indonesia |
Background: Cytokine storm has been widely known to contribute to the development of the critical condition in patients with coronavirus disease 2019 (COVID-19), and studies had been conducted to assess the potential aspect of cytokine storm elimination by performing therapeutic plasma exchange (TPE). However, contradictory findings were observed. The objective of this study was to assess the association between TPE and the reduction of mortality of critically ill COVID-19 patients. Methods: A meta-analysis was conducted by collecting data from PubMed, Scopus, and Web of Science. Data on the mortality rate of critically ill COVID-19 patients treated with TPE plus standard of care and that of patients treated with standard of care alone were analyzed using a Z test. Results: We included a total of four papers assessing the association between TPE and the risk of mortality among critically ill COVID-19 patients. Our findings suggested that critically ill COVID-19 patients treated with TPE had lower risk of mortality compared to those without TPE treatment. Conclusion: Our study has identified the potential benefits of TPE in reducing the risk of mortality among critically ill COVID-19 patients. © 2021 Wardhani SO et al. |
COVID-19therapeutic plasma exchangecytokine stormtreatment |
coronavirus disease 2019; critically ill patient; cytokine storm; human; meta analysis; mortality rate; plasma exchange; Review; systematic review; critical illness; cytokine release syndrome; plasma exchange; COVID-19; Critical Illness; Cytokine Release Syndrome; Humans; Plasma Exchange; SARS-CoV-2 |
F1000 Research Ltd |
20461402 |
|
35083038 |
Review |
Q1 |
1099 |
3793 |
|
|
640 |
Yulia D.E., Pambudy I.M., Amanda L. |
57225947931;57327482000;57225929959; |
Review of Corticosteroid Use in Pediatric Cataract Surgery |
2021 |
Open Ophthalmology Journal |
15 |
1 |
|
251 |
257 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122381840&doi=10.2174%2f1874364102115010251&partnerID=40&md5=443070a1878e6bcf97e1132e3d5f8357 |
Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Yulia, D.E., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Pambudy, I.M., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Amanda, L., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Introduction: Following pediatric cataract surgery, an intense inflammatory response is related to various complications, including posterior capsule opacification (PCO), which is a visually threatening incidence that can lead to visual axis opacification (VAO). Although corticosteroids are essentially effective in reducing inflammation, potential ocular side effects are a remaining concern. Objective: This study aimed to review the efficacy and safety of corticosteroid drugs and their administration routes in pediatric patients who underwent cataract surgery Methods: A literature search was conducted from four electronic databases using keywords selected a priori. Identified articles were sorted according to the type of corticosteroid used, route of administration, and outcome measures, including inflammatory response and ocular side effects. Results: Five studies were included with one case series, one retrospective case-control, and three clinical trials. The total number of subjects was 311 patients, with an age range of six weeks to 15 years old. Four studies analyzed the use of triamcinolone acetonide intracamerally, which was superior to topical steroids. Most of the studies reported a decrease in inflammatory parameters. The outcome of PCO and VAO varied between studies. Nearly all the studies observed elevated intraocular pressure (IOP) as an ocular side effect. Conclusion: Various corticosteroids and different delivery routes can be used to ameliorate inflammation in pediatric cataract surgery. However, there is promising evidence suggesting intracameral steroids as substantially beneficial in reducing inflammatory parameters. Due to the limited number of studies reviewed, no firm conclusion regarding the superior steroid preparation or route of administration can be inferred. This review highlights the need for further studies. © 2021 Yulia et al. |
Corticosteroid; Drug administration; Inflammation; Ocular side effect; Pediatric cataract surgery; Posterior capsular opacification |
corticosteroid; cataract; cataract extraction; drug administration route; drug safety; human; inflammation; intraocular pressure; outcome assessment; pediatric patient; pediatric surgery; Review; side effect; topical drug administration |
Bentham Science Publishers |
18743641 |
|
|
Review |
Q2 |
670 |
7468 |
|
|
642 |
Soetisna T.W., Namretta L., Tirta E.S., Catur M.M.S.P., Ronidipta B., Tjubandi A. |
57214887740;57394531400;57221753958;57394432600;57394432700;57211055979; |
The importance of differentiating types of myxoma: a case report |
2021 |
Cor et Vasa |
63 |
6 |
|
733 |
735 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122153861&doi=10.33678%2fCOR.2021.063&partnerID=40&md5=ece88060ac36e8ce762e466c1383e95a |
Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia; Department of Surgery, Faculty of Medicine, Universitas Indonesia, Indonesia |
Soetisna, T.W., Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia, Department of Surgery, Faculty of Medicine, Universitas Indonesia, Indonesia; Namretta, L., Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia; Tirta, E.S., Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia; Catur, M.M.S.P., Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia; Ronidipta, B., Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia; Tjubandi, A., Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia, Department of Surgery, Faculty of Medicine, Universitas Indonesia, Indonesia |
Myxoma shows unspecific symptoms similar to other cardiac disorders. Late resection of myxoma will worsen output such as congestive heart failure, cardiac arrhythmia, and cardiac embolism, causing sudden death. Early diagnosis and surgical excision of cardiac myxomas, especially with the villous surface, must be done as soon as possible. Additional diagnostic examination was needed to define types of myxoma for earlier treatment to prevent complications. We present a case of atrial myxoma which was diagnosed and treated earlier than the median time reviewed by the previous study. This paper focuses on the importance of early diagnosis and defining types of myxoma. © 2021, ÄŒKS. |
Myxoma; Tumor; Villous surface |
adult; cardiopulmonary bypass; case report; clinical article; color Doppler flowmetry; dyspnea; early diagnosis; heart atrium myxoma; heart atrium septum defect; human; human tissue; male; middle aged; mitral valve regurgitation; physical examination; Review; sinus bradycardia; sternotomy; transthoracic echocardiography |
Czech Society of Cardiology Z.S |
00108650 |
|
|
Review |
Q4 |
177 |
20889 |
|
|
643 |
Bangun K., Halim J., Tania V. |
36902624600;57219398869;57394760300; |
Repair of Protruding Bilateral Cleft Lip and Palate With Staged Premaxilla Setback Osteotomy, Cheiloplasty, and Palatoplasty in Trisomy 17p Patient: A Review of Syndromic Clinical Characteristic |
2021 |
Cleft Palate-Craniofacial Journal |
|
|
|
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122134129&doi=10.1177%2f10556656211069820&partnerID=40&md5=065c5cf3acef75c03e60e1e90acf33a2 |
Cleft and Craniofacial Center, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Division of Plastic Reconstructive and Aesthetic Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, Indonesia |
Bangun, K., Cleft and Craniofacial Center, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, Division of Plastic Reconstructive and Aesthetic Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, Indonesia; Halim, J., Cleft and Craniofacial Center, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, Division of Plastic Reconstructive and Aesthetic Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, Indonesia; Tania, V., Cleft and Craniofacial Center, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, Division of Plastic Reconstructive and Aesthetic Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, Indonesia |
Objective : Chromosome 17 duplication is correlated with an increased risk of developmental delay, birth defects, and intellectual disability. Here, we reported a female patient with trisomy 17 on the whole short arm with bilateral complete cleft lip and palate (BCLP). This study will review the surgical strategies to reconstruct the protruding premaxillary segment, cleft lip, and palate in trisomy 17p patient. Case Presentation : The patient had heterozygous pathogenic duplication of chromosomal region chr17:526-18777088 on almost the entire short arm of chromosome 17. Beside the commonly found features of trisomy 17p, the patient also presented with BCLP with a prominent premaxillary portion. Premaxillary setback surgery was first performed concomitantly with cheiloplasty. The ostectomy was performed posterior to the vomero-premaxillary suture (VPS). The premaxilla was firmly adhered to the lateral segment and the viability of philtral flap was not compromised. Two-flap palatoplasty with modified intravelar veloplasty (IVV) was performed 4 months after. Conclusion : Successful positioning of the premaxilla segment, satisfactory lip aesthetics, and vital palatal flap was obtained from premaxillary setback, primary cheiloplasty, and subsequent palatoplasty in our trisomy 17p patient presenting with BLCP. Postoperative premaxillary stability and patency of the philtral and palatal flap were achieved. Longer follow-up is needed to evaluate the long-term effects of our surgical techniques on inhibition of midfacial growth. However, the benefits that the patient received from the surgery in improving feeding capacity and facial appearance early in life outweigh the cost of possible maxillary retrusion. © 2021, American Cleft Palate-Craniofacial Association. |
bilateral cleft lip and palate; premaxillary osteotomy; trisomy 17 |
|
SAGE Publications Ltd |
10556656 |
|
|
Review |
Q2 |
641 |
7859 |
|
|
648 |
Sungkar A. |
55110453800; |
Preterm birth in low-resource setting |
2021 |
Donald School Journal of Ultrasound in Obstetrics and Gynecology |
15 |
2 |
|
175 |
178 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121540929&doi=10.5005%2fjp-journals-10009-1695&partnerID=40&md5=6bdfb4b0abc69737097e5332647cdcc6 |
Fetomaternal Division, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Cipto Mangunkusumo National Hospital, Jakarta, Indonesia |
Sungkar, A., Fetomaternal Division, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia, Cipto Mangunkusumo National Hospital, Jakarta, Indonesia |
Preterm labor (PTL) is a global problem which is a complex disease with a high rate of morbidity and mortality, also has long-term consequences for the baby and the family. The well-known morbidities related to PTL are respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage, retinopathy of prematurity, and anemia of prematurity. In a developing country, the management of PTL is limited by poor health systems, low education level of the mother, poor financial support, lack of facility and trained health personnel, and demographic barriers. This limitation leads to high morbidity and mortality of preterm birth, especially in developing countries. It is important to reduce the rate of preterm birth by preventing the event. Several risk factors have been identified and are avoidable and preventable, such as smoking, bacterial infection, poor nutritional status, and malnourished mothers. Strategies to prevent PTL have been proposed in primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. © Jaypee Brothers Medical Publishers. 2021. |
Management; Morbidity and mortality; Preterm labor; Risk factor |
fibronectin; folic acid; homocysteine; iron; trace element; zinc; allergy; body mass; cigarette smoking; early diagnosis; endocrine disease; gestational weight gain; graft rejection; human; hyperhomocysteinemia; hypertension; infertility therapy; intrauterine growth retardation; intrauterine infection; ischemia; macronutrient; morbidity; mortality; multiple pregnancy; non communicable disease; nutritional deficiency; preeclampsia; pregnancy diabetes mellitus; premature labor; prepregnancy care; Review; risk factor; transvaginal echography; uterine cervix carcinoma in situ; uterine cervix incompetence; vascular disease |
Jaypee Brothers Medical Publishers (P) Ltd |
0973614X |
|
|
Review |
Q4 |
162 |
22036 |
|
|
667 |
Lesmana C.R.A., Paramitha M.S., Gani R.A., Lesmana L.A. |
8977683000;57212562901;23495930300;55920139300; |
The role of endoscopic ultrasound for portal hypertension in liver cirrhosis |
2021 |
Journal of Medical Ultrasonics |
|
|
|
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119500644&doi=10.1007%2fs10396-021-01165-4&partnerID=40&md5=72338502ade4f82a944b72db4fee4c65 |
Hepatobiliary Division, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Digestive Disease and GI Oncology Center, Medistra Hospital, Jakarta, Indonesia |
Lesmana, C.R.A., Hepatobiliary Division, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia, Digestive Disease and GI Oncology Center, Medistra Hospital, Jakarta, Indonesia; Paramitha, M.S., Hepatobiliary Division, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Gani, R.A., Hepatobiliary Division, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Lesmana, L.A., Digestive Disease and GI Oncology Center, Medistra Hospital, Jakarta, Indonesia |
Chronic liver disease is still a major problem because disease progression will ultimately lead to liver cirrhosis. Portal hypertension is the hallmark in advanced liver disease management. By establishing portal vein access, endoscopic ultrasound (EUS) has been utilized in various clinical applications. In comparison to standard upper gastrointestinal endoscopy, EUS-Doppler has been shown to be a better modality for detecting esophageal and gastric varices along with peri-esophageal collateral veins, para-esophageal collateral veins, and perforating veins, and may be used to objectively predict the recurrence of bleeding. EUS-guided portal vein catheterization has also been proposed to overcome the limitations of trans-jugular approaches. The combination of EUS-elastography and azygos vein evaluation can also enhance the diagnostic accuracy of each modality. Another well-known implementation of EUS-guided procedures is in the management of ascites; particularly in paracentesis and ascitic fluid analysis. In addition, the most common clinical application of EUS in the treatment of portal hypertension is through vascular therapy or creation of intrahepatic portosystemic shunts. Major drawbacks of EUS mainly revolve around technical difficulties, the high cost of the procedure, as well as the requirement of more studies in humans to evaluate EUS-guided advanced therapeutic modalities in portal hypertension. © 2021, The Author(s), under exclusive licence to The Japan Society of Ultrasonics in Medicine. |
Endoscopic ultrasound; Liver cirrhosis; Portal hypertension |
|
Springer |
13464523 |
|
|
Review |
#N/A |
#N/A |
#N/A |
|
|
676 |
Agarwal A., Sharma R.K., Gupta S., Boitrelle F., Finelli R., Parekh N., Durairajanayagam D., Saleh R., Arafa M., Cho C.L., Farkouh A., Rambhatla A., Henkel R., Vogiatzi P., Tadros N., Kavoussi P., Ko E., Leisegang K., Kandil H., Palani A., Salvio G., Mostafa T., Rajmil O., Banihani S.A., Schon S., Le T.V., Birowo P., Çeker G., Alvarez J., Molina J.M.C., Ho C.C.K., Calogero A.E., Khalafalla K., Duran M.B., Kuroda S., Colpi G.M., Zini A., Anagnostopoulou C., Pescatori E., Chung E., Caroppo E., Dimitriadis F., Pinggera G.-M., Busetto G.M., Balercia G., Elbardisi H., Taniguchi H., Park H.J., Rosas I.M., de la Rosette J., Ramsay J., Bowa K., Simopoulou M., Rodriguez M.G., Sabbaghian M., Martinez M., Gilani M.A.S., Al-Marhoon M.S., Kosgi R., Cannarella R., Micic S., Fukuhara S., Parekattil S., Jindal S., Abdel-Meguid T.A.-A., Morimoto Y., Shah R. |
7401480880;56464514400;8924915200;35306701900;57210196522;57196694810;55520166400;7006807491;23098964500;57197761284;57208753862;23398404000;16194084100;55926424800;6701691160;13805293700;54894624400;55522599700;57225096159;57195328571;57191592841;14060837800;6602414666;55393128900;36119073400;57327390400;6504153311;57445145100;7402573357;57214102315;57327957600;7006656219;57188552644;57216609982;57327256700;7004721256;7005212511;57225111834;7003338300;57327111700;6602342322;15126468500;6603547664;37049750600;56259951900;56711976600;22836833700;57327528100;57225111015;7102844406;7103327153;24721453900;6506988003;57225094450;24451370900;57214939051;57327818500;9247352000;57195955297;56033761100;7006493137;8635237400;6506341654;57214937086;6508134167;36051984500;23470471000; |
Sperm vitality and necrozoospermia: diagnosis, management, and results of a global survey of clinical practice |
2021 |
World Journal of Men's Health |
39 |
|
210149 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118736952&doi=10.5534%2fwjmh.210149&partnerID=40&md5=776ce144f9bcad4451df84b64415ccd7 |
American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Reproductive Biology, Fertility Preservation, Andrology, CECOS, Poissy Hospital, Poissy, France; Paris Saclay University, UVSQ, INRAE, BREED, Jouy-en-Josas, France; Department of Urology, Cleveland Clinic, Cleveland, OH, United States; Department of Physiology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt; Department of Urology, Hamad Medical Corporation, Doha, Qatar; Department of Urology, Weill Cornell Medical-Qatar, Doha, Qatar; SH Ho Urology Center, Department of Surgery, Chinese University of Hong Kong, Hong Kong; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, United States; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom; Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa; LogixX Pharma, Berkshire, Theale, United Kingdom; Andromed Health and Reproduction, Fertility Diagnostics Laboratory, Maroussi, Greece; Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, United States; Austin Fertility and Reproductive Medicine/Westlake IVF, Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States; Department of Urology, Loma Linda University Health, Loma Linda, CA, United States; Department of Physiology, School of Natural Medicine, Faculty of Community and Health Sciences, University of the Western Cape, Bellville, South Africa; Fakih IVF Fertility Center, Abu Dhabi, United Arab Emirates; Department of Biochemistry, College of Medicine, University of Garmian, Kalar, Iraq; Department of Endocrinology and Metabolic Diseases, Polytechnic University of Marche, Ancona, Italy; Department of Andrology, Sexology and STIs, Faculty of Medicina, Cairo University, Cairo, Egypt; Department of Andrology, Fundacio Puigvert, Barcelona, Spain; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, United States; Department of Andrology and Urology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Viet Nam; Department of Andrology, Binh Dan Hospital, Ho Chi Minh City, Viet Nam; Department of Urology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Urology, Samsun Vezirköprü State Hospital, Samsun, Turkey; Centro ANDROGEN, La Coruña, Spain; Servicio de Urología, Hospital Clínico de Barcelona, Barcelona, Spain; Department of Surgery, School of Medicine, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Malaysia; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Department of Urology, Samsun Training and Research Hospital, Samsun, Turkey; Andrology and IVF Unit, Procrea Institute, Lugano, Switzerland; Department of Surgery, McGill University, Montreal, QC, Canada; IVF Clinic “Akeso-Embryo ART”, Athens, Greece; Andrology and Reproductive Medicine Unit, Gynepro Medical, Bologna, Italy; Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia; AndroUrology Centre, Brisbane, QLD, Australia; Reproductive and IVF Unit, Andrology Outpatients Clinic, ASL Bari, Conversano (Ba), Italy; 1st Urology Department, School of Medicine, Aristotle University, Thessaloniki, Greece; Department of Urology, Innsbruck Medical University, Innsbruck, Austria; Department of Urology and Renal Transplantation, University of Foggia, Ospedali Riuniti of Foggia, Foggia, Italy; Department of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, Japan; Department of Urology, Pusan National University School of Medicine, Busan, South Korea; Medical Research Institute, Pusan National University Hospital, Busan, South Korea; Citmer Reproductive Medicine, IVF LAB, Mexico City, Mexico; Department of Urology, Medipol Mega University Hospital, Istanbul, Turkey; Department of Andrology, Hammersmith Hospital, London, United Kingdom; Department of Urology, Michael Chilufya Sata Copperbelt University School of Medicine, Ndola, Zambia; Department of Experimental Physiology, School of Health Sciences, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Departamento Docencia e Investigación, Hospital Militar Campo de Mayo, Universidad Barcelo, Buenos Aires, Argentina; Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran; Section of Urology, University of Santo Tomas Hospital, Manila, Philippines; Department of Surgery, Urology Division, Sultan Qaboos University, Muscat, Oman; Department of Urology and Andrology, AIG Hospitals, Gachibowli, Hyderabad, India; Department of Andrology, Uromedica Polyclinic, Belgrade, Serbia; Department of Urology, Graduate School of Medicine, Osaka University, Osaka, Japan; Avant Concierge Urology, University of Central Florida, Winter Garden, FL, United States; Department of Andrology and Reproductive Medicine, Jindal Hospital, Meerut, India; Department of Urology, Faculty of Medicine, Minia University, Minia, Egypt; Department of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; HORAC Grand Front Osaka Clinic, Osaka, Japan; Division of Andrology, Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India |
Agarwal, A., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Sharma, R.K., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Gupta, S., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Boitrelle, F., Reproductive Biology, Fertility Preservation, Andrology, CECOS, Poissy Hospital, Poissy, France, Paris Saclay University, UVSQ, INRAE, BREED, Jouy-en-Josas, France; Finelli, R., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Parekh, N., Department of Urology, Cleveland Clinic, Cleveland, OH, United States; Durairajanayagam, D., Department of Physiology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia; Saleh, R., Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt; Arafa, M., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States, Department of Urology, Hamad Medical Corporation, Doha, Qatar, Department of Urology, Weill Cornell Medical-Qatar, Doha, Qatar; Cho, C.L., SH Ho Urology Center, Department of Surgery, Chinese University of Hong Kong, Hong Kong; Farkouh, A., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Rambhatla, A., Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, United States; Henkel, R., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom, Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa, LogixX Pharma, Berkshire, Theale, United Kingdom; Vogiatzi, P., Andromed Health and Reproduction, Fertility Diagnostics Laboratory, Maroussi, Greece; Tadros, N., Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, United States; Kavoussi, P., Austin Fertility and Reproductive Medicine/Westlake IVF, Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States; Ko, E., Department of Urology, Loma Linda University Health, Loma Linda, CA, United States; Leisegang, K., Department of Physiology, School of Natural Medicine, Faculty of Community and Health Sciences, University of the Western Cape, Bellville, South Africa; Kandil, H., Fakih IVF Fertility Center, Abu Dhabi, United Arab Emirates; Palani, A., Department of Biochemistry, College of Medicine, University of Garmian, Kalar, Iraq; Salvio, G., Department of Endocrinology and Metabolic Diseases, Polytechnic University of Marche, Ancona, Italy; Mostafa, T., Department of Andrology, Sexology and STIs, Faculty of Medicina, Cairo University, Cairo, Egypt; Rajmil, O., Department of Andrology, Fundacio Puigvert, Barcelona, Spain; Banihani, S.A., Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan; Schon, S., Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, United States; Le, T.V., Department of Andrology and Urology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Viet Nam, Department of Andrology, Binh Dan Hospital, Ho Chi Minh City, Viet Nam; Birowo, P., Department of Urology, Cipto Mangunkusumo General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Çeker, G., Department of Urology, Samsun Vezirköprü State Hospital, Samsun, Turkey; Alvarez, J., Centro ANDROGEN, La Coruña, Spain; Molina, J.M.C., Servicio de Urología, Hospital Clínico de Barcelona, Barcelona, Spain; Ho, C.C.K., Department of Surgery, School of Medicine, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Malaysia; Calogero, A.E., Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Khalafalla, K., Department of Urology, Hamad Medical Corporation, Doha, Qatar; Duran, M.B., Department of Urology, Samsun Training and Research Hospital, Samsun, Turkey; Kuroda, S., American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, United States; Colpi, G.M., Andrology and IVF Unit, Procrea Institute, Lugano, Switzerland; Zini, A., Department of Surgery, McGill University, Montreal, QC, Canada; Anagnostopoulou, C., IVF Clinic “Akeso-Embryo ART”, Athens, Greece; Pescatori, E., Andrology and Reproductive Medicine Unit, Gynepro Medical, Bologna, Italy; Chung, E., Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia, AndroUrology Centre, Brisbane, QLD, Australia; Caroppo, E., Reproductive and IVF Unit, Andrology Outpatients Clinic, ASL Bari, Conversano (Ba), Italy; Dimitriadis, F., 1st Urology Department, School of Medicine, Aristotle University, Thessaloniki, Greece; Pinggera, G.-M., Department of Urology, Innsbruck Medical University, Innsbruck, Austria; Busetto, G.M., Department of Urology and Renal Transplantation, University of Foggia, Ospedali Riuniti of Foggia, Foggia, Italy; Balercia, G., Department of Endocrinology and Metabolic Diseases, Polytechnic University of Marche, Ancona, Italy; Elbardisi, H., Department of Urology, Hamad Medical Corporation, Doha, Qatar, Department of Urology, Weill Cornell Medical-Qatar, Doha, Qatar; Taniguchi, H., Department of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, Japan; Park, H.J., Department of Urology, Pusan National University School of Medicine, Busan, South Korea, Medical Research Institute, Pusan National University Hospital, Busan, South Korea; Rosas, I.M., Citmer Reproductive Medicine, IVF LAB, Mexico City, Mexico; de la Rosette, J., Department of Urology, Medipol Mega University Hospital, Istanbul, Turkey; Ramsay, J., Department of Andrology, Hammersmith Hospital, London, United Kingdom; Bowa, K., Department of Urology, Michael Chilufya Sata Copperbelt University School of Medicine, Ndola, Zambia; Simopoulou, M., Department of Experimental Physiology, School of Health Sciences, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Rodriguez, M.G., Departamento Docencia e Investigación, Hospital Militar Campo de Mayo, Universidad Barcelo, Buenos Aires, Argentina; Sabbaghian, M., Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran; Martinez, M., Section of Urology, University of Santo Tomas Hospital, Manila, Philippines; Gilani, M.A.S., Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran; Al-Marhoon, M.S., Department of Surgery, Urology Division, Sultan Qaboos University, Muscat, Oman; Kosgi, R., Department of Urology and Andrology, AIG Hospitals, Gachibowli, Hyderabad, India; Cannarella, R., Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Micic, S., Department of Andrology, Uromedica Polyclinic, Belgrade, Serbia; Fukuhara, S., Department of Urology, Graduate School of Medicine, Osaka University, Osaka, Japan; Parekattil, S., Avant Concierge Urology, University of Central Florida, Winter Garden, FL, United States; Jindal, S., Department of Andrology and Reproductive Medicine, Jindal Hospital, Meerut, India; Abdel-Meguid, T.A.-A., Department of Urology, Faculty of Medicine, Minia University, Minia, Egypt, Department of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Morimoto, Y., HORAC Grand Front Osaka Clinic, Osaka, Japan; Shah, R., Division of Andrology, Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India |
Sperm vitality testing is a basic semen examination that has been described in the World Health Organization (WHO) Laboratory Manual for the Examination and Processing of Human Semen from its primary edition, 40 years ago. Several methods can be used to test sperm vitality, such as the eosin-nigrosin (E-N) stain or the hypoosmotic swelling (HOS) test. In the 6th (2021) edition of the WHO Laboratory Manual, sperm vitality assessment is mainly recommended if the total motility is less than 40%. Hence, a motile spermatozoon is considered alive, however, in certain conditions an immotile spermatozoon can also be alive. Therefore, the differentiation between asthenozoospermia (pathological decrease in sperm motility) and necrozoospermia (pathological decrease in sperm vitality) is important in directing further investigation and management of infertile patients. The causes leading to necrozoospermia are diverse and can either be local or general, testicular or extra-testicular. The andrological management of necrozoospermia depends on its etiology. However, there is no standardized treatment available presently and practice varies among clinicians. In this study, we report the results of a global survey to understand current practices regarding the physician order of sperm vitality tests as well as the management practices for necrozoospermia. Laboratory and clinical scenarios are presented to guide the reader in the management of necrozoospermia with the overall objective of establishing a benchmark ranging from the diagnosis of necrozoospermia by sperm vitality testing to its clinical management. Copyright © 2021 Korean Society for Sexual Medicine and Andrology |
Asthenozoospermia; Eosine Yellowish-(YS); Infertility; Nigrosin; Spermatozoa; Vitality |
asthenospermia; clinical practice; diagnostic procedure; ejaculation; eosin nigrosin staining; human; hypoosmotic swelling test; infertility therapy; intracytoplasmic sperm injection; male infertility; necrozoospermia; physician; quality control; Review; semen analysis; semen parameters; sperm viability; spermatozoon density; spermatozoon motility; testicular sperm extraction |
Korean Society for Sexual Medicine and Andrology |
22874208 |
|
|
Review |
#N/A |
#N/A |
#N/A |
|
|
677 |
Vandenplas Y., Brough H.A., Fiocchi A., Miqdady M., Munasir Z., Salvatore S., Thapar N., Venter C., Vieira M.C., Meyer R. |
57223670656;37064383600;7006595735;26664817800;7801694370;55390678300;8337607800;35944268900;8270521000;7404078956; |
Current guidelines and future strategies for the management of cow’s milk allergy |
2021 |
Journal of Asthma and Allergy |
14 |
|
|
1244 |
1256 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118723222&doi=10.2147%2fJAA.S276992&partnerID=40&md5=2b3b3cbc9500f0760551157f099bf4c4 |
Vrije Universiteit Brussel (VUB), UZ Brussel, KidZ Health Castle, Brussels, Belgium; Department Women and Children’s Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King’s College London, London, United Kingdom; Children’s Allergy Service, Evelina Children’s Hospital, Guy’s and St, Thomas’s NHS Foundation Trust, London, United Kingdom; Translational Research in Pediatric Specialities Area, Division of Allergy, Bambino Gesù Children’s Hospital, IRCCS, Piazza Sant’Onofrio, Rome, Italy; Department of Pediatrics, Sheikh Khalifa Medical City, College of Medicine & Health Sciences, Khalifa University, Khalifa, United Arab Emirates; Department of Child Health, Ciptomangunkusumo Hospital-Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Pediatric Department, Hospital “F. Del Ponte”, University of Insubria, Varese, Italy; Gastroenterology, Hepatology and Liver Transplant, Queensland Children’s Hospital, Brisbane, QLD, Australia; University of Colorado, Children’s Hospital Colorado, Denver, CO, United States; Center for Pediatric Gastroenterology-Hospital Pequeno Príncipe, Curitiba, Brazil; Department of Paediatrics, Imperial College, London, United Kingdom; Department Nutrition and Dietetics, University of Winchester, Winchester, United Kingdom |
Vandenplas, Y., Vrije Universiteit Brussel (VUB), UZ Brussel, KidZ Health Castle, Brussels, Belgium; Brough, H.A., Department Women and Children’s Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom, Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King’s College London, London, United Kingdom, Children’s Allergy Service, Evelina Children’s Hospital, Guy’s and St, Thomas’s NHS Foundation Trust, London, United Kingdom; Fiocchi, A., Translational Research in Pediatric Specialities Area, Division of Allergy, Bambino Gesù Children’s Hospital, IRCCS, Piazza Sant’Onofrio, Rome, Italy; Miqdady, M., Department of Pediatrics, Sheikh Khalifa Medical City, College of Medicine & Health Sciences, Khalifa University, Khalifa, United Arab Emirates; Munasir, Z., Department of Child Health, Ciptomangunkusumo Hospital-Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Salvatore, S., Pediatric Department, Hospital “F. Del Ponte”, University of Insubria, Varese, Italy; Thapar, N., Gastroenterology, Hepatology and Liver Transplant, Queensland Children’s Hospital, Brisbane, QLD, Australia; Venter, C., University of Colorado, Children’s Hospital Colorado, Denver, CO, United States; Vieira, M.C., Center for Pediatric Gastroenterology-Hospital Pequeno Príncipe, Curitiba, Brazil; Meyer, R., Department of Paediatrics, Imperial College, London, United Kingdom, Department Nutrition and Dietetics, University of Winchester, Winchester, United Kingdom |
Exclusive breast feeding is recommended in all guidelines as the first choice feeding. Cow milk allergy (CMA) can be diagnosed by a diagnostic elimination diet for 2 to 4 weeks with a hypo-allergenic formula, followed by a challenge test with intact cow milk protein. The most often used hypo-allergenic formula for the diagnostic elimination diet and the therapeutic diet is a CM based extensive hydrolysate. CM-based partial hydrolysates cannot be recommended in the management of CMA because of insufficient efficacy and possible reactions, but about half of the infants with CMA may tolerate a partial hydrolysate. The pros and cons of other dietary options are discussed in this paper. The use of an amino acid-based formula and/or rice based hydrolysate formula during the diagnostic elimination and therapeutic diet is debated. When available, there is sufficient evidence to consider rice hydrolysates as an adequate alternative to CM-based hydrolysates, since some infants will still react to the CM hydrolysate. The pros and cons of dietary options such as soy formula, buckwheat, almond, pea or other plant based dietary products are discussed. Although the majority of the plant-based beverages are nutritionally inadequate, some are nutritionally adapted for toddlers. However, accessibility and content vary by country and, thus far there is insufficient evidence on the efficacy and tolerance of these plant-based drinks (except for soy formula and rice hydrolysates) to provide an opinion on them. Conclusion: A diagnostic elimination diet, followed by a challenge remains the diagnostic standard. The use of an awareness tool may result in a decrease of delayed diagnosis. Breastmilk remains the ideal source of nutrition and when not available a CM extensively hydrolyzed formula, rice hydrolysate or amino acid formula should be recommended. More evidence is needed regarding plant-based drinks. © 2021 Vandenplas et al. |
Amino acid formula; Challenge test; Cow milk allergy; Hydrolysate; Plant-based drink; Rice hydrolysate; Soy formula |
alpha 1 antitrypsin; amino acid based formula; beta defensin; beta lactoglobulin; calcium; calgranulin; casein hydrolysate; cyanocobalamin; folic acid; food allergen; immunoglobulin A; immunoglobulin E; immunoglobulin G4; iodine; partial hydrolysate formula; prebiotic agent; probiotic agent; short chain fatty acid; soybean protein; tumor necrosis factor; unclassified drug; vitamin; allergenicity; almond; asthma; awareness; beverage; Bifidobacteriaceae; breast feeding; buckwheat; buffalo milk; camel milk; child growth; Clinical awareness score; colic; cow milk; Cow’s Milk related Symptom Score; dietary compliance; dietary fiber; donkey milk; double blind procedure; eczema; elimination diet; eosinophilic esophagitis; evidence based practice; facial angioedema; food intake; futurology; health |
Dove Medical Press Ltd |
11786965 |
|
|
Review |
Q1 |
1162 |
3475 |
|
|